SYRS: Syros Pharmaceuticals Inc Stock Price Quote - NASDAQ GS - Bloomberg
S&P 500
5,201.27
Arrow Down
–0.65%
Nasdaq
16,489.66
Arrow Down
–1.48%
US 10 Yr
4.51
Arrow Up
+0.27%
FTSE 100
8,275.38
Arrow Up
+0.54%
Crude Oil
77.24
Arrow Down
–0.86%
Gold
2,356.20
Arrow Down
–0.44%
Euro
1.08
Arrow Up
+0.14%
Pound/Dollar
1.27
Arrow Down
–0.02%
Search
    Markets
    Data
    Search

      Syros Pharmaceuticals Inc
      SYRS:US

      Nasdaq GS (USD)· Market open
      Arrow Down
      –0.12–2.40%
      Delayed price as of.

      Overview

      Key Statistics

      Related News

      Syros Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company focuses on developing treatments for cancer and immune-mediated diseases, as well as building a pipeline of gene control medicines. Syros Pharmaceuticals conducts business worldwide.

      620 Memorial Drive Suite 300 Cambridge, MA 02139 United States

      www.syros.com

      Income Statement

      Annual

      Balance Sheet

      Overview

      Key Statistics

      Before it’s here, it’s on the Bloomberg Terminal
      Bloomberg Terminal LEARN MORE
      View Your WatchlistArrow Right
      HomeBTV+Market DataOpinionAudioOriginalsMagazineEvents
      News
      MarketsEconomicsTechnologyPoliticsGreenCryptoAI
      Work & Life
      WealthPursuitsBusinessweekCityLabEqualityPursuitsWork Shift
      Market Data
      StocksCommoditiesRates & BondsCurrenciesFuturesSectorsEconomic Calendar
      Explore
      NewslettersExplainersThe Big TakeGraphicsSubmit a TipAbout Us
      Terms of ServiceTrademarksPrivacy Policy
      CareersMade in NYCAdvertise
      Ad Choices
      Help©2024 Bloomberg L.P. All Rights Reserved.